November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Amazon Refreshes AI Story With New Chips, Models And Platform Tools
Amazon: Multiple Margin Levers Drive Earnings Growth
Nvidia’s Pullback: The Calm Before Takeoff
Tesla Faces An Uphill Battle In 2025
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Medtronic (MDT) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 5, 2024 (17:28)
Sector: HealthcareThe share price of Medtronic plc. (MDT) now
Analysts predictions
Full report|
This Week
|
Bullish | Opinions: 1 (1/0/0) |
|
Previous Week
|
Neutral | Opinions: Na |
|
Two Weeks Ago
|
Bullish | Opinions: 1 (1/0/0) |
|
Three Weeks Ago
|
Neutral | Opinions: Na |
Are you interested in Medtronic plc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medtronic stock price in 2025, 2026, 2027. How much will one Medtronic share be worth in 2025 - 2027?
When should I take profit in Medtronic stock? When should I record a loss on Medtronic stock? What are analysts' forecasts for Medtronic stock? What is the future of Medtronic stock? We forecast Medtronic stock performance using neural networks based on historical data on Medtronic stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Medtronic stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medtronic shares. This happens once a day.
Historical and forecast chart of Medtronic stock
The chart below shows the historical price of Medtronic stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Medtronic stock price can be found in the table below.
Long-term forecasts by years.
Medtronic plc. Analysts predictions review
As of now, Panda has combed through 2 analytical articles which are directly related to MDT from the last 30 days. Out of these, 2 clearly showcase a bullish trend, while 0 see a bearish trend as the more likely scenario, and 0 stay neutral.
To identify the dominant trend, we took into account analytical articles from the past 30 days, spanning from Nov 19, 2024 to Dec 02, 2024.
Medtronic: An Attractive Buy with Rising Estimates Despite Sector Challenges
In his latest analytical financial article, Mike Zaccardi, CFA, CMT, presents a compelling case for maintaining a bullish stance on MDT stock. With an impressive portfolio of 1,577 publications since 2022 and a significant following of 7,066 subscribers, Zaccardi's insights are both popular and widely respected in the financial community. His credibility is notably high, as reflected by his authority within the industry, suggesting his analyses are both informed and impactful. With a remarkable frequency of contributions, Zaccardi has established himself as a reliable voice in financial analysis circles. Readers can trust his bullish outlook on MDT stock as a well-considered position, grounded in extensive research and industry expertise.
Key Theses of the Medtronic Stock Review
- Medtronic is deemed a buy due to its attractive valuation and steady EPS growth despite sector-wide challenges.
- The company's Q2 results exceeded expectations, prompting a raise in FY 2025 revenue and earnings estimates.
- Medtronic faces risks such as supply chain issues, competition, policy changes, and currency fluctuations.
- Resistance levels in the low $90s and support between $82-83.55 indicate potential upside if resistance is broken.
Key Factors Influencing Medtronic's Stock Price
Quarterly Earnings Performance
Medtronic's Q2 non-GAAP EPS of $1.26 beat forecasts, and revenue rose by 5% YOY, leading to raised FY 2025 estimates. Such performance boosts investor confidence and supports stock price growth.
Technical Chart Patterns
Resistance at $92-93 and support between $82-83.55 provide technical indicators for investors. Breaching these points could lead to significant momentum changes in the stock.
Dividends and Free Cash Flow Yield
A dividend yield of 3.2% and a free cash flow yield slightly below 5% suggest strong profitability. These metrics make the stock attractive to income-focused investors, likely supporting the price.
Supply Chain and Competition Risks
Ongoing supply chain issues and competition in the MedTech space could hamper growth. While these factors pose risks, the company projects improvement, moderating their impact.
Currency Fluctuations
Medtronic faces a 5% negative impact from currency fluctuations in its EPS estimate. While this is a challenge, currency impacts are often temporary, reducing their lasting effect on stock pricing.
Review the original Analysis
Medtronic's Steady Gains Meet Unpredictable Profit Challenges
Edmund Ingham presents a compelling analysis in his latest article, offering a Bullish perspective on MDT stock. With an impressive track record of 871 publications since 2018, Ingham’s frequent contributions highlight his deep engagement and commitment to financial discourse. Boasting a substantial subscriber base of over 12,500 individuals, his insights resonate with a broad audience, underlining the popularity and influence of his financial assessments. The author’s credibility is underscored by an authoritative reputation, as evidenced by an exceptional record reflecting highly authoritative opinions in the industry. Readers can confidently explore Ingham’s well-founded optimism for MDT stock, supported by both widespread audience trust and a prolific body of work.
Key Theses of the Review
- Medtronic's revenue growth remains consistent yet mild, characterized by mid-single-digit increases despite new product launches.
- The company's share price stagnation is linked to unpredictable net income and modest innovation in its offerings.
- Medtronic’s management is optimistic about its growth trajectory but lacks specific long-term growth guidance, keeping market sentiment moderate.
- Medtronic is positioned for potential high single-digit growth through strategic M&A, innovation, and consistent product launches.
Factors Influencing MDT Company's Stock Price
Revenue Growth
Organic revenue growth at 4.75%-5% is a positive, reflecting a consistent performance that stabilizes the company's financial outlook. Despite this, the moderate growth rate does not strongly excite investors, indicating a lukewarm reaction.
Net Income Consistency
Medtronic's net income unpredictability directly impacts investor confidence and share price stability. Inconsistent earnings make the stock less attractive, thus applying downward pressure on its valuation.
Innovation and Product Launches
Ongoing product launches suggest a strategic focus on innovation, yet these innovations are often incremental rather than industry-changing. This gradual innovation keeps growth steady but does not significantly boost the stock.
CEO and Management Outlook
While CEO Geoff Martha's optimism signals confidence, the absence of detailed long-term guidance tempers enthusiasm among investors. Without specific future growth targets, market reactions remain cautious.
Market Position and Competition
Medtronic's foothold in high-growth markets like diabetes and cardiovascular supports its market presence, providing slight strength to its stock price. However, intense competition limits significant value appreciation.
Review the original Analysis Commentary
Medtronic is making steady progress with its consistent revenue growth, marking improvements in the mid-single digits. This reflects a reliable but moderate performance that invites cautious optimism among investors. However, the company's ability to spark excitement remains limited due to merely organic growth percentages that, while stabilizing, do not set off market fireworks. The stock's journey is further hampered by unpredictable net income figures, keeping investors wary as it adds a layer of caution to the valuation equation.
In the coming month, while the steady pace offers a Bullish trend, the average influence strength across key factors points to a nuanced stock movement. Critical aspects like moderate innovations and the lack of long-term guidance from management only reinforce a holding pattern rather than a scaling of new heights. For investors, this mixed bag translates into a backdrop of stability with a potential for upside adjustment if consistency improves and innovation becomes more groundbreaking.
Medtronic is a large medical device company headquartered in Dublin, Ireland. It is one of the largest medical device companies. Works in over 140 countries. Medtronic has six main divisions, each of which develops and manufactures devices and treatments for a variety of chronic conditions including heart failure, Parkinson’s disease, urinary incontinence, Down’s syndrome, obesity, chronic pain, diabetes and others, for a total of more than 30 different diseases.
In 2017, the company earned more than $ 29 billion, which is 9 billion more than in 2015, the net income for the 2017 financial year of the company increased by $ 1 billion compared to 2015 and amounted to more than $ 5 billion.
Medtronic was founded in 1949 as a medical device repair company in a garage in northeastern Minneapolis by Earl Bakken and Palmer Hermundsl. While working for the company, Earl Bakken met Dr. Walton Lillehei, one of the first cardiac surgeons. Lillehei was disappointed with the pacemakers of the time that had to be plugged in, especially after the 1957 power outage on Halloween. Lillehei then proposed to Bakken the idea of a battery-operated pacemaker.
Medtronic daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 07 | 84.99 | 84.38 | 86.23 | 2.20 |
| Dec 08 | 85.35 | 84.10 | 86.66 | 3.04 |
| Dec 09 | 85.45 | 85.01 | 86.72 | 2.01 |
| Dec 10 | 84.68 | 83.72 | 85.70 | 2.37 |
| Dec 11 | 84.63 | 83.75 | 85.31 | 1.86 |
| Dec 12 | 85.51 | 85.02 | 86.37 | 1.59 |
| Dec 13 | 84.95 | 84.44 | 86.27 | 2.17 |
| Dec 14 | 84.18 | 83.07 | 85.06 | 2.39 |
| Dec 15 | 85.56 | 84.35 | 86.73 | 2.82 |
| Dec 16 | 85.96 | 85.37 | 87.23 | 2.17 |
| Dec 17 | 85.15 | 84.40 | 85.88 | 1.76 |
| Dec 18 | 86.44 | 85.86 | 87.57 | 1.99 |
| Dec 19 | 87.46 | 86.06 | 88.74 | 3.11 |
| Dec 20 | 89.00 | 88.31 | 90.18 | 2.12 |
| Dec 21 | 88.86 | 88.01 | 90.18 | 2.46 |
| Dec 22 | 88.72 | 87.71 | 89.91 | 2.51 |
| Dec 23 | 88.74 | 88.33 | 89.45 | 1.27 |
| Dec 24 | 88.11 | 87.02 | 89.15 | 2.45 |
| Dec 25 | 87.69 | 86.32 | 88.76 | 2.82 |
| Dec 26 | 88.27 | 87.88 | 89.56 | 1.91 |
| Dec 27 | 89.15 | 88.03 | 90.42 | 2.71 |
| Dec 28 | 89.05 | 88.37 | 89.99 | 1.83 |
| Dec 29 | 88.32 | 87.56 | 89.04 | 1.69 |
| Dec 30 | 88.35 | 87.19 | 89.64 | 2.82 |
| Dec 31 | 89.16 | 87.88 | 89.95 | 2.35 |
| Jan 01 | 89.88 | 88.67 | 90.45 | 2.01 |
| Jan 02 | 90.06 | 89.25 | 90.44 | 1.33 |
| Jan 03 | 89.36 | 88.84 | 90.77 | 2.17 |
| Jan 04 | 88.44 | 87.42 | 89.26 | 2.10 |
| Jan 05 | 87.52 | 87.14 | 88.33 | 1.37 |
Medtronic Daily Price Targets
Medtronic Stock Forecast 12-07-2024.
Forecast target price for 12-07-2024: $84.99.
Negative dynamics for Medtronic shares will prevail with possible volatility of 2.149%.
Pessimistic target level: 84.38
Optimistic target level: 86.23
Medtronic Stock Forecast 12-08-2024.
Forecast target price for 12-08-2024: $85.35.
Positive dynamics for Medtronic shares will prevail with possible volatility of 2.955%.
Pessimistic target level: 84.10
Optimistic target level: 86.66
Medtronic Stock Forecast 12-09-2024.
Forecast target price for 12-09-2024: $85.45.
Positive dynamics for Medtronic shares will prevail with possible volatility of 1.971%.
Pessimistic target level: 85.01
Optimistic target level: 86.72
Medtronic Stock Forecast 12-10-2024.
Forecast target price for 12-10-2024: $84.68.
Negative dynamics for Medtronic shares will prevail with possible volatility of 2.312%.
Pessimistic target level: 83.72
Optimistic target level: 85.70
Medtronic Stock Forecast 12-11-2024.
Forecast target price for 12-11-2024: $84.63.
Negative dynamics for Medtronic shares will prevail with possible volatility of 1.825%.
Pessimistic target level: 83.75
Optimistic target level: 85.31
Medtronic Stock Forecast 12-12-2024.
Forecast target price for 12-12-2024: $85.51.
Positive dynamics for Medtronic shares will prevail with possible volatility of 1.564%.
Pessimistic target level: 85.02
Optimistic target level: 86.37
MDT (MDT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 92.08 | 89.59 | 97.05 | 7.69 |
| Feb. | 88.67 | 86.01 | 92.75 | 7.27 |
| Mar. | 91.15 | 86.23 | 98.36 | 12.33 |
| Apr. | 94.25 | 91.61 | 98.50 | 6.99 |
| May. | 94.54 | 87.73 | 101.06 | 13.19 |
| Jun. | 91.51 | 87.76 | 96.54 | 9.10 |
| Jul. | 96.09 | 90.13 | 101.37 | 11.09 |
| Aug. | 96.18 | 92.14 | 99.84 | 7.71 |
| Sep. | 98.30 | 91.91 | 104.79 | 12.29 |
| Oct. | 102.23 | 95.07 | 109.18 | 12.92 |
| Nov. | 98.96 | 96.88 | 103.31 | 6.23 |
| Dec. | 95.89 | 88.60 | 102.80 | 13.81 |
Medtronic forecast for this year
Medtronic Stock Prediction for Jan 2025
An uptrend is forecast for this month with an optimal target price of $92.0786. Pessimistic: $89.59. Optimistic: $97.05
Medtronic Stock Prediction for Feb 2025
An downtrend is forecast for this month with an optimal target price of $88.6717. Pessimistic: $86.01. Optimistic: $92.75
Medtronic Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $91.1545. Pessimistic: $86.23. Optimistic: $98.36
Medtronic Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $94.2537. Pessimistic: $91.61. Optimistic: $98.50
Medtronic Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $94.5365. Pessimistic: $87.73. Optimistic: $101.06
Medtronic Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $91.5113. Pessimistic: $87.76. Optimistic: $96.54
Medtronic Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $96.0869. Pessimistic: $90.13. Optimistic: $101.37
Medtronic Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $96.183. Pessimistic: $92.14. Optimistic: $99.84
Medtronic Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $98.299. Pessimistic: $91.91. Optimistic: $104.79
Medtronic Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $102.231. Pessimistic: $95.07. Optimistic: $109.18
Medtronic Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $98.9595. Pessimistic: $96.88. Optimistic: $103.31
Medtronic Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $95.8918. Pessimistic: $88.60. Optimistic: $102.80
Medtronic (MDT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 102.32 | 95.26 | 109.79 | 13.23 |
| Feb | 111.93 | 105.89 | 114.40 | 7.44 |
| Mar | 122.57 | 115.09 | 127.35 | 9.62 |
| Apr | 123.18 | 116.78 | 129.22 | 9.63 |
| May | 126.14 | 120.71 | 129.17 | 6.54 |
| Jun | 130.43 | 122.86 | 136.17 | 9.77 |
| Jul | 125.34 | 118.32 | 130.98 | 9.67 |
| Aug | 124.71 | 118.73 | 128.95 | 7.93 |
| Sep | 115.73 | 109.14 | 120.25 | 9.24 |
| Oct | 112.61 | 107.32 | 118.69 | 9.58 |
| Nov | 108.22 | 104.11 | 114.28 | 8.90 |
| Dec | 111.68 | 104.09 | 118.60 | 12.24 |
Medtronic (MDT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 111.68 | 108.44 | 115.48 | 6.09 |
| Feb | 109.56 | 105.83 | 117.99 | 10.31 |
| Mar | 107.04 | 104.04 | 114.32 | 8.99 |
| Apr | 108.54 | 103.54 | 117.22 | 11.67 |
| May | 111.58 | 103.77 | 118.72 | 12.59 |
| Jun | 105.77 | 102.92 | 109.69 | 6.17 |
| Jul | 96.99 | 90.11 | 102.72 | 12.28 |
| Aug | 102.14 | 99.68 | 104.28 | 4.41 |
| Sep | 108.47 | 101.42 | 113.57 | 10.70 |
| Oct | 114.11 | 107.15 | 122.78 | 12.73 |
| Nov | 120.16 | 111.26 | 123.64 | 10.01 |
| Dec | 116.67 | 112.94 | 119.94 | 5.84 |
Medtronic information and performance
20 ON HATCH, LOWER HATCH STREET, DUBLIN, IE
Market capitalization of the Medtronic plc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDT shares in the company outstanding by the market price of one share.
EBITDA of Medtronic is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Medtronic (MDT) stock dividend
Medtronic last paid dividends on 09/27/2024. The next scheduled payment will be on 10/11/2024. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Commentary
Medtronic is showing encouraging signs for investors. With a notable Q2 performance featuring a 5% revenue boost and an EPS better than expected, the company is projecting optimism by raising its fiscal year 2025 estimates. Technical indicators hint that if the current resistance at $92-93 is overcome, there could be a promising upswing in Medtronic’s stock price. Not to forget, the company's solid dividend yield of 3.2% coupled with strong free cash flow adds to its appeal for investors seeking income stability.
However, it’s essential to keep an eye on some lurking risks. Supply chain disruptions, competitive pressures, and the unfavorable currency changes require cautious optimism. Despite these challenges, Medtronic forecasts alleviate some potential investor concerns, suggesting adaptability and resilience. Considering the overall positive trends and mitigating factors, Medtronic's stock seems poised to retain its attractiveness in the short to mid-term. Investors might find an optimistic atmosphere around Medtronic within the next 15 days and even slightly more encouraging development over the next month.